The general office of the General Administration of the people's Republic of China solicits public opinions on matters related to the review and approval of drug packaging materials, pharmaceutical excipients and drugs (Draft for comments)

Source: CFDA May 13, 2016 to implement the opinions of the State Council on the reform of the review and approval system for pharmaceutical and medical devices (GF [2015] 44) No.), simplify the drug approval process, change the packaging materials and containers (hereinafter referred to as drug packaging materials) and pharmaceutical auxiliary materials that are directly in contact with drugs from independent approval to review and approve together when approving the drug registration application, and the food and drug administration has organized the drafting of the announcement on relevant matters of review and approval of drug packaging materials and drugs (Draft for comments), which is now submitted to the society Public consultation will be held Please feedback the modification opinions to the General Administration of food and Drug Administration (Department of drug and cosmetic registration) by email before May 23, 2016 Contact: Wang Lin email: wanglin@cfda.gov.cn Annex: Announcement on matters related to the review and approval of drug packaging materials, pharmaceutical excipients and drugs (Draft for comments) General Office of food and Drug Administration May 12, 2016 Appendix: Announcement on matters related to review and approval of drug packaging materials and drug related materials (Draft for comments) Docx